These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29119938)

  • 1. Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature.
    Sousa JB; Fresco P; Diniz C; Goncalves J
    Recent Pat Anticancer Drug Discov; 2018; 13(1):40-69. PubMed ID: 29119938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
    Borah P; Deka S; Mailavaram RP; Deb PK
    Curr Pharm Des; 2019; 25(26):2792-2807. PubMed ID: 31333097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.
    Gorain B; Choudhury H; Yee GS; Bhattamisra SK
    Curr Pharm Des; 2019; 25(26):2828-2841. PubMed ID: 31333092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives.
    Bahreyni A; Khazaei M; Rajabian M; Ryzhikov M; Avan A; Hassanian SM
    J Pharm Pharmacol; 2018 Feb; 70(2):191-196. PubMed ID: 29057476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors.
    Jamwal S; Mittal A; Kumar P; Alhayani DM; Al-Aboudi A
    Curr Pharm Des; 2019; 25(26):2892-2905. PubMed ID: 31333104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine receptor ligands: where are we, and where are we going?
    Tuccinardi T; Martinelli A
    Curr Top Med Chem; 2010; 10(10):941. PubMed ID: 20681944
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy.
    Franco R; Rivas-Santisteban R; Navarro G; Reyes-Resina I
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in adenosine receptor ligands and their potential as novel drugs.
    Müller CE; Jacobson KA
    Biochim Biophys Acta; 2011 May; 1808(5):1290-308. PubMed ID: 21185259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile effects and receptor analysis of adenosine-receptors in human detrusor muscle from stable and neuropathic bladders.
    Pakzad M; Ikeda Y; McCarthy C; Kitney DG; Jabr RI; Fry CH
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):921-9. PubMed ID: 27185496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity.
    Betti M; Catarzi D; Varano F; Falsini M; Varani K; Vincenzi F; Pasquini S; di Cesare Mannelli L; Ghelardini C; Lucarini E; Dal Ben D; Spinaci A; Bartolucci G; Menicatti M; Colotta V
    J Med Chem; 2019 Aug; 62(15):6894-6912. PubMed ID: 31306001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of Adenosine Receptors: The State of the Art.
    Borea PA; Gessi S; Merighi S; Vincenzi F; Varani K
    Physiol Rev; 2018 Jul; 98(3):1591-1625. PubMed ID: 29848236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors.
    Jensen K; Johnson LA; Jacobson PA; Kachler S; Kirstein MN; Lamba J; Klotz KN
    Naunyn Schmiedebergs Arch Pharmacol; 2012 May; 385(5):519-25. PubMed ID: 22249336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
    Deb PK; Deka S; Borah P; Abed SN; Klotz KN
    Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature.
    Kaur R; Kaur P; Sharma S; Singh G; Mehndiratta S; Bedi PM; Nepali K
    Recent Pat Anticancer Drug Discov; 2015; 10(1):23-71. PubMed ID: 25230072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode.
    Lagarias P; Vrontaki E; Lambrinidis G; Stamatis D; Convertino M; Ortore G; Mavromoustakos T; Klotz KN; Kolocouris A
    J Chem Inf Model; 2018 Apr; 58(4):794-815. PubMed ID: 29485875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical structure-activity studies of adenosine A1 ligands: requirements for receptor affinity.
    Dooley MJ; Kono M; Suzuki F
    Bioorg Med Chem; 1996 Jun; 4(6):923-34. PubMed ID: 8818243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribose modified nucleosides and nucleotides as ligands for purine receptors.
    Jacobson KA; Ravi RG; Nandanan E; Kim HS; Moro S; Kim YC; Lee K; Barak D; Marquez VE; Ji XD
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):333-41. PubMed ID: 11563046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A1 adenosine receptors and their ligands: overview and recent developments.
    Müller CE
    Farmaco; 2001; 56(1-2):77-80. PubMed ID: 11347971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.